Stock listing
NASDAQ:PTLA Portola Pharmaceuticals Inc Stock
Follow Portola Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PTLA
$18.03 USD
Close on Jul 2, 2020 · No longer trades
- Lowest – highest close
- $5.78 – $66.04 USDSince May 22, 2013 · lowest Mar 17, 2020 · highest Jul 21, 2017
Delisted NASDAQ:PTLA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PTLA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Portola Pharmaceuticals Inc on 6ix
- Decks
- 2 decks · latest Jan 8, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (January 2019) | Corporate update | 21 slides | Jan 8, 2019 |
| Investor Presentation (September 2017) | Investor deck | 31 slides | Sep 11, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ted W Love Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Seagen Inc (Director · Aug 16, 2020 – Dec 14, 2023 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past) | Director · Sep 18, 2019 – Jul 2, 2020 · Past |
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Director · May 21, 2013 – Jun 5, 2013 · Past |
| John H. Johnson Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past) | Director · Jun 17, 2016 – Jul 2, 2020 · Past |
| Scott Garland Other companies: Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Jan 7, 2026); LB Pharmaceuticals Inc (Chairman of the Board, LB Pharmaceuticals · Since at least Sep 10, 2025); Olema Pharmaceuticals, Inc. (Director · Since at least Oct 16, 2023); ALX Oncology Holdings Inc. (Chairman · Since at least Nov 28, 2022); Day One Biopharmaceuticals Inc (Director · Since at least Aug 16, 2021); Calithera Biosciences, Inc. (Director · Jul 10, 2020 – Jun 1, 2022 · Past); Karyopharm Therapeutics Inc. (Director · Nov 3, 2014 – Jun 6, 2019 · Past); Relypsa Inc (SVP & Chief Commercial Officer · Oct 31, 2014 – Sep 1, 2016 · Past); Exelixis, Inc. (EVP & Chief Commerical Officer · Oct 20, 2011 – Sep 18, 2013 · Past) | President and CEO, Director · Oct 8, 2018 – Jul 2, 2020 · Past |
| Jean-Jacques Bienaimé Other companies: Ascendis Pharma A/S (Director · Since at least Mar 23, 2026); Keros Therapeutics, Inc. (Director · Since at least Jun 1, 2024); Immunome, Inc. (Director · Since at least Nov 7, 2023); Incyte Corporation (Director · Since at least Jan 20, 2015); Immunic, Inc. (Director · Apr 16, 2014 – Sep 24, 2018 · Past); InterMune Inc (Director · Mar 26, 2012 – Sep 29, 2014 · Past); NeurogesX Inc (Director · May 1, 2007 – Feb 7, 2012 · Past); BioMarin Pharmaceutical Inc. (Director · Jan 3, 2006 – May 20, 2024 · Past) | Director · May 21, 2013 – May 16, 2014 · Past |
| Nicholas Galakatos Other companies: Tourmaline Bio Inc. (Director · May 6, 2021 – May 6, 2021 · Past); Praxis Precision Medicines, Inc. (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Aug 3, 2016 · Past); IVERIC bio Inc (Director · Sep 25, 2013 – Jan 11, 2016 · Past); NanoString Technologies Inc (Director · Jun 25, 2013 – Mar 25, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – Jun 1, 2011 · Past); Affymax Inc (Director · Dec 14, 2006 – May 28, 2009 · Past) | Director · May 21, 2013 – Jun 27, 2014 · Past |
| Hollings Renton Other companies: AnaptysBio, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jan 25, 2017); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 7, 2023 · Past); Kythera Biopharmaceuticals Inc (Director · Dec 31, 2014 – Oct 1, 2015 · Past); Affymax Inc (Director · Jun 9, 2009 – Jun 13, 2012 · Past); Rigel Pharmaceuticals, Inc. (Director · May 31, 2006 – May 15, 2013 · Past); Cepheid (Director · Apr 27, 2006 – Nov 4, 2016 · Past); Onyx Pharmaceuticals Inc (President and CEO, Director · Jan 19, 2006 – Feb 19, 2008 · Past) | Director · May 21, 2013 – Jul 2, 2020 · Past |
| Jean George Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Feb 5, 2021 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Jun 7, 2018 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Jan 22, 2020 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past) | Director · May 21, 2013 – May 28, 2013 · Past |
| Laura Brege Other companies: Edgewise Therapeutics, Inc. (Director · Since at least Mar 25, 2021); Mirum Pharmaceuticals, Inc. (Board Member · Since at least Jul 17, 2019); ACADIA Pharmaceuticals Inc. (Director · Since at least Jun 10, 2016); Pacira BioSciences, Inc. (Director · Since at least Jun 6, 2016); Aratana Therapeutics Inc (Director · Jun 24, 2016 – Jul 27, 2018 · Past); Dynavax Technologies Corporation (Director · May 31, 2016 – May 30, 2019 · Past) | Director · Jun 17, 2016 – Jul 2, 2020 · Past |
| Mardi C. Dier Other companies: Madrigal Pharmaceuticals, Inc. (EVP and CFO · Since at least Mar 11, 2024); Prelude Therapeutics Incorporated (Director · Since at least Sep 24, 2020); ORIC Pharmaceuticals, Inc. (Board Member · Since at least Apr 23, 2020); Acelyrin, Inc. (CFO and CBO · May 4, 2023 – May 9, 2023 · Past); Ultragenyx Pharmaceutical Inc. (CFO & Executive Vice President · Oct 12, 2020 – Oct 14, 2022 · Past); Adamas Pharmaceuticals Inc (Director · Oct 10, 2017 – Jun 2, 2021 · Past) | EVP and CFO · May 21, 2013 – Jul 2, 2020 · Past |
All 27 people
| Person | Seat |
|---|---|
| Rajiv Patni Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Aug 24, 2026); BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Reata Pharmaceuticals Inc (EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past); Adamas Pharmaceuticals Inc (Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past); Ocera Therapeutics Inc (Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past) | EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past |
| Charles Homcy Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); BridgeBio Pharma, Inc. (Director · Since at least Jun 27, 2019); Population Health Investment Co Inc (Director · Nov 17, 2020 – Jan 26, 2021 · Past); Pliant Therapeutics, Inc. (Director · Jun 2, 2020 – Jun 29, 2021 · Past); Global Blood Therapeutics Inc (Director · Oct 3, 2017 – Jun 20, 2018 · Past) | Director · Jun 8, 2018 – Jan 2, 2019 · Past |
| David Stump Other companies: Regenxbio Inc. (Independent Board Member · Since at least Oct 14, 2015); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Dendreon Corp (Director · Jun 2, 2010 – Jan 3, 2014 · Past); Sunesis Pharmaceuticals Inc (Director · Jun 18, 2009 – Jun 30, 2020 · Past); Human Genome Sciences Inc (Exec. Vice President · Mar 10, 2009 – Jul 30, 2012 · Past) | Director · Sep 24, 2015 – Jul 2, 2020 · Past |
| Henry Ward Wolff Other companies: Sunesis Pharmaceuticals Inc (Director · Feb 2, 2018 – Jun 30, 2020 · Past); Calithera Biosciences, Inc. (Director · Dec 2, 2014 – Jun 1, 2022 · Past); Oruka Therapeutics, Inc. (Sr. VP Finance and CFO · Jul 24, 2006 – Feb 1, 2007 · Past); Sangamo Therapeutics, Inc. (Exec VP & CFO · Jun 7, 2006 – Dec 12, 2016 · Past); Abgenix Inc (CFO & SVP, Finance · Mar 24, 2006 – Apr 1, 2006 · Past) | Director · May 21, 2013 – Jul 2, 2020 · Past |
| Dennis M Fenton Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); AnaptysBio, Inc. (Director · Since at least Mar 5, 2018); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past); Pfenex Inc (Director · May 6, 2016 – May 5, 2017 · Past) | Director · Jun 17, 2016 – Jul 2, 2020 · Past |
| Farah Champsi Other companies: Population Health Investment Co Inc (Director · Nov 17, 2020 – Jan 26, 2021 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past); Trevena, Inc. (Director · Jan 30, 2014 – Dec 10, 2014 · Past); Chimerix Inc (Director · Apr 10, 2013 – Oct 23, 2013 · Past) | Director · May 21, 2013 – May 28, 2013 · Past |
| John Moriarty Other companies: Kardigan, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 17, 2026); Avidity Biosciences, Inc (Chief Legal Officer · Since at least Aug 1, 2024); Olema Pharmaceuticals, Inc. (EVP, Ch. Legal Officer & Sec. · Sep 19, 2020 – Feb 1, 2023 · Past); Alexion Pharmaceuticals Inc (EVP & General Counsel · Dec 10, 2012 – Feb 6, 2018 · Past) | EVP, General Counsel · Mar 12, 2018 – Jul 2, 2020 · Past |
| William Lis Other companies: Zai Lab Ltd. (Board Member · Since at least Jan 1, 2021); Jasper Therapeutics, Inc. (Director · Sep 24, 2021 – Oct 13, 2023 · Past); Eidos Therapeutics Inc (Director · Dec 4, 2018 – Jan 26, 2021 · Past) | Chief Executive Officer, Director · May 21, 2013 – Jul 28, 2018 · Past |
| John Curnutte Other companies: Pliant Therapeutics, Inc. (Board Member · Since at least Jun 2, 2020); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past) | EVP R&D · May 21, 2013 – May 17, 2019 · Past |
| Peggy V Phillips Other companies: Arbutus Biopharma Corporation (Director · Dec 31, 2014 – Dec 31, 2014 · Past); Dynavax Technologies Corporation (Director · May 29, 2013 – May 23, 2024 · Past) | Director · May 21, 2013 – May 28, 2013 · Past |
| Robert Califf Other companies: Centessa Pharmaceuticals PLC (Director · May 27, 2021 – May 27, 2021 · Past); Cytokinetics, Incorporated (Director · Feb 8, 2018 – Jan 3, 2022 · Past) | Director · May 21, 2013 – Jun 27, 2014 · Past |
| Jeffrey W Bird Other companies: Forty Seven Inc (Director · Jun 12, 2019 – Apr 7, 2020 · Past) | Director · Jun 13, 2019 – Jul 2, 2020 · Past |
| Michael Kitt Other companies: Innoviva, Inc. (Sr. Vice President Development · Feb 8, 2006 – Jun 2, 2008 · Past) | Senior VP and CMO · May 21, 2013 – May 21, 2013 · Past |
| Sheldon L Koenig Other companies: Esperion Therapeutics, Inc. (President and CEO, Director · Since at least Dec 15, 2020) | EVP, Chief Commercial Officer · Jan 28, 2019 – Jul 2, 2020 · Past |
| Ernie Meyer | EVP and CHRO · Aug 20, 2018 – Jul 2, 2020 · Past |
| Glenn P Brame | EVP, CTOO · Jun 25, 2018 – Jul 2, 2020 · Past |
| John H Lawrence III | SVP, Chief Medical Officer · Nov 6, 2017 – Jan 31, 2018 · Past |
Log in to ask 6ix AI your own questions about Portola Pharmaceuticals Inc.